Comparison of complement dependent lytic, hemagglutination inhibition and microneutralization antibody responses in influenza vaccinated individuals

被引:15
作者
Co, Mary Dawn T. [1 ]
Cruz, John [1 ]
Takeda, Akira [1 ]
Ennis, Francis A. [1 ]
Terajima, Masanori [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA
关键词
influenza virus; vaccine; complement dependent lytic; hemagglutination inhibition; microneutralization; antibody; VIRUS-INFECTED-CELLS; HUMAN MONOCLONAL-ANTIBODIES; CYTO-TOXIC LYMPHOCYTES; MEDIATED LYSIS; MEASLES; PATHWAY;
D O I
10.4161/hv.21025
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Virus specific, non-neutralizing antibodies such as complement dependent lytic (CDL) antibodies may reduce morbidity following infection through the clearance of infectious virus particles and infected cells. We examined hemagglutination inhibition (HAI), microneutralization (MN) and CDL antibody titers to influenza A H1 and H3 virus strains in 23 healthy young adults who received the 2005-2006 trivalent inactivated influenza vaccine. Post vaccination, we detected statistically significant increases in MN and CDL antibodies but not in HAI antibodies. Statistically significantly higher fold increases in CDL antibodies post vaccination were seen compared with MN and HAI antibodies post vaccination. However, the overall fold increases were modest, likely related to the fact that most of the subjects had received influenza vaccination previously. This study showed that influenza vaccination is not only capable of increasing the level of antibodies that neutralize virus but also antibodies that can cause lysis of infected cells. The biological significance of these CDL antibodies merits further investigation in clinical studies.
引用
收藏
页码:1218 / 1222
页数:5
相关论文
共 25 条
[1]   MF59®-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis [J].
Banzhoff, Angelika ;
Pellegrini, Michele ;
Del Giudice, Giuseppe ;
Fragapane, Elena ;
Groth, Nicola ;
Podda, Audino .
INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2008, 2 (06) :243-249
[2]   Seroprotection rate, mean fold increase, seroconversion rate:: which parameter adequately expresses seroresponse to influenza vaccination? [J].
Beyer, WEP ;
Palache, AM ;
Lüchters, G ;
Nauta, J ;
Osterhaus, ADME .
VIRUS RESEARCH, 2004, 103 (1-2) :125-132
[3]   Discordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine [J].
Co, Mary Dawn T. ;
Orphin, Laura ;
Cruz, John ;
Pazoles, Pamela ;
Rothman, Alan L. ;
Ennis, Francis A. ;
Terajima, Masanori .
VACCINE, 2008, 26 (16) :1990-1998
[4]  
de Jong J C, 2003, Dev Biol (Basel), V115, P63
[5]   Characterization of antibody responses to annual influenza vaccination over four years in a healthy elderly population [J].
Gardner, EM ;
Bernstein, ED ;
Dran, S ;
Munk, G ;
Gross, P ;
Abrutyn, E ;
Murasko, DM .
VACCINE, 2001, 19 (32) :4610-4617
[6]   Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses [J].
Grandea, Andres G., III ;
Olsen, Ole A. ;
Cox, Thomas C. ;
Renshaw, Mark ;
Hammond, Philip W. ;
Chan-Hui, Po-Ying ;
Mitcham, Jennifer L. ;
Cieplak, Witold ;
Stewart, Shaun M. ;
Grantham, Michael L. ;
Pekosz, Andrew ;
Kiso, Maki ;
Shinya, Kyoko ;
Hatta, Masato ;
Kawaoka, Yoshihiro ;
Moyle, Matthew .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (28) :12658-12663
[7]  
HICKS JT, 1976, J IMMUNOL, V117, P208
[8]  
HICKS JT, 1978, J IMMUNOL, V121, P1437
[9]   The hemagglutination inhibition antibody responses to an inactivated influenza vaccine among healthy adults: With special reference to the prevaccination antibody and its interaction with age [J].
Hirota, Y ;
Kaji, M ;
Ide, S ;
Goto, S ;
Oka, T .
VACCINE, 1996, 14 (17-18) :1597-1602
[10]   Enhancement of neutralizing activity of influenza virus-specific antibodies by serum components [J].
Mozdzanowska, Krystyna ;
Feng, JingQi ;
Eid, Mark ;
Zharikova, Darya ;
Gerhard, Walter .
VIROLOGY, 2006, 352 (02) :418-426